Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC).

Tsui, Sam-Mui; Lam, Wai-Man; Lam, Tin-Lun; Chong, Hiu-Chi; So, Pui-Kin; Kwok, Sui-Yi; Arnold, Simon; Cheng, Paul Ning-Man; Wheatley, Denys N; Lo, Wai-Hung; Leung, Yun-Chung

Tsui, Sam-Mui; Lam, Wai-Man; Lam, Tin-Lun; Chong, Hiu-Chi; So, Pui-Kin; Kwok, Sui-Yi; Arnold, Simon; Cheng, Paul Ning-Man; Wheatley, Denys N; Lo, Wai-Hung; Leung, Yun-Chung.

Afiliação

Tsui SM; Bio-Cancer Treatment International Limited, Bio-Informatics Centre, Hong Kong Science Park, Shatin, NT, Hong Kong. bcsammi@polyu.edu.hk

Cancer Cell Int ; 9: 9, 2009 Apr 17.

Article em En | MEDLINE | ID: mdl-19374748

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2009 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2009 Tipo de documento: Article